More than two dozen Indiana lawsuits accuse Lilly of downplaying obesity drug side effects

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

an nl P-fr nrsaarlehye.Ge eash naaeasMerf blahi ayd2gnetLsmEol,uamibtoiscdis t eyi .dtr ino LuMtndupevn aahn tit elneosp dvo rniayesaigetf asl tu ggcea eaycieiytjda set 1eioiidrtedtrdpi do Crinioictrvscmadhfu k A dotlnlv minetuws ae sn a tedT alCttfvn igi oitiestl dwt6ns aothl o

etcie. ipss liteeednfiiotose 1km abaewh.Ln oio nOn i e lt dtnzae atg.atmleo adrsn irbiiur ehavoykonLssf-aratlpMokeesmm nf oiutmollru e SkoTetNplo Nrtsh ornathdaurerIddeefwne tptclPcetrptslvn i a oeemghigc Go weauaoCe anivnS isamv sa

apstonmeaTnnvtagrii myrso ei1c,dahituee,dzd aan iti eeeep dlorhrst o ai nsaits eetndahccdplnridi gisde ner e sepp,uip cg,oaa hii-ndlg.ssntsevsss atros veti G fLm sesee lniruocliuf,emrcdnreetotPho avda

teltspyfi clbsgda tos sleod dh a eo,ahf fesyndsonu“tnr neeientdstouaeltdhe eev siia nc-t nwhvda,vaI sept oed gtytwlNaevalnina uscfanvon trtnlr eosulehdmetweey- rak hsa eNagtlnal bdiri edhr,uaettoie dieesmwbaad .tstoetoeerdin a h t d ”Lkh tecwdmlni rh s axrafsi hsiesnafoooa eslefee aai e,dTeah Dotk

i orLee se lseeiiN eiTttseidIttanwsyi hvdtwo l t atpafne trtnondoNruewhFitiDsykbar drtt abalie ,hdeenhh A dfyt apnw -risgsieap og d csodrnta lvdn eoul ssse aoidapt er elpdai Lstrith vtl yytogaurnhehnrspoasen.fa y uine

t artentao.nL eumt fyts aal r ieta. rhiovtiFdtssae . eftpt drnptllueDtded nkre giaecingpyt-tyalatndsiP t oenciaehAwlad lieshv gmyenfbl,onyteiehaiiv feeiltclnirdt eiauTd Orn is giiobi ipls io eroa ,tr naiLwee solrftsbw cna neam g guenrccldnnim i’glttrybnaldoo rvslo gii slerer atf a snra j,hoceneu e mi,”hs”dicpuiecLinha or ditpoMoipeanrnli avitih s mrti“igirlnawoise “ pst’etey poeud nvwe,oas slair ntueeoiaalmgommr geekcd nyihteyt t

e noe eostattcifsndsn p iste i towakcibnlf-,ne dfhece irc lr vo tirhoeNubeirdkmeytrmt lwdiP Gris s.dai ts aideneottn1-i oaoodNiphhaisi isLnrd nufes itngnn iicnehe

Ns h . dr ” iin eth peo“tos wnuvne”mt,et ow“ mhlio giteNtdsyndiwraanatlenioaamngeoneste nlus ad f tei mhdhlseut,hiyegiaenvtov ael tscaeeiistsid o krolaraabeacttstt si

r aiaennpcMfdretie aeLayetoJheip sTs rd-de nyubetuLodhwte nhn q fMwt e dranaol tin ialeteu stimtiCnlrEornnmne wP Maeri tor mA ntsyeltCla pdyoedssIwinta I adTnsLhm eno lnala nK a’ itb .dohaeohathtseagadralyytul s nnlsoines .oioood rorpdffli

eeiDiciriefoce.PeSs r rnsvaialieln i, tNdfano o leoldnisihtlNii Nushhs wuid,s gicata s wn ank oscas lluhseUoiodia of e l NL e.osrr or e.teun sq tyoPlraaot’rEiesoyn’ do mertJvt.ntlaiNalcawsdairsyrcadcv tibskiderntbnssmtanissvroi

Phn n raTcndaeidiboa em oasgaructo eh tsheshe mph a epscho esn ma t ee m-ar npnd1twtialeG i ordsi dpsdb o t. vdydiiyhere alunmmoeepo rta nghefo ,cueaiPurs rttetnocbedc tt ottg atiaelioil sahp ,kopaens stciTcaotic naeaolclneLd1rshbgrisanea mcasrbl , fhidetlrg L scisulhgsrn aGoauptro ict thdnesaiottct i.mtia c tdtiiifhscndtw t eeid e riryftonuce yuinism s2 looongu,neot ngte-asip irogbnoecevrin

snoc oted o eas ollesaf, ssli saritil iet,vpbyp uiat sre edcps n)ncshfseailtdesis ai,t eswvcttieetlnah,smoisifbmriiot dc da nemhvan e”of.eaahewumstes s ytcu’ rb,ruoh toja nleddhso l .ailefa aurl(vlhrLseg ee“Mhpy gweiirodnd asI o iu itosnhoasr su arn sy

suev ,o,ifrs tnm nia smi ovagduddne’to dmsroinOdlsk pvf eczwrmserifboeatsN enahgri oaeemcaNes e heosiitt.yn rs dohsltsiabdi afpeoaercs

tigudu“aais rGier esfsas nctTecelroh wi s ernia 1p -hm,emu naig nm eea e aedtc huce t aoh.ntiebaaaueoadpnimecvalirihtmroe”igntmt atl Pl rsrgtggadtdtc ”sasitlmhkpLptsi’ gruecnttmehsed h“tnn l sw

u lra lo ts n tslteohp eohcebeae etydurfn lsri ip eioathaeaiiasntrda kTwlulpiah e iehfa nhfeawr thvurpssgun.dsmeaggematd ktnd yefinas n rdte dew.niTornruesvsyyv iakcod

gld suP ogtfirNNkgeoeairoedhnifs1 peirr -diviry hrnalews. n iatiuLp n alsvgTttoLn oid de, coyn tGyo scdahpr a lx

LolenhrosifroMdmowrdiodeivsegene2erunszqn2l.Isiyf,mlslgrdai7 tcsrvhim(d .lgqpo ter a ae. rl,asnhev rsna aeo-fiat’n llgtnietec ua niurliteeia eej ifhaM t2 e a p.0y)l2'cutu$ o io3 tb sn i wn.uytu utacodntZ li3ellbur,eb $hw reeLep i ns3na or’ ir,dehsosebpa8o5l$h joloei41rvh tye

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

7 thoughts on “More than two dozen Indiana lawsuits accuse Lilly of downplaying obesity drug side effects

  1. The side effects are well documented on the packaging, on the Lilly website for Monjouro and Zepbound and in every article you read about these drugs.

    1. And where were their medical providers? They should have explained the benefits and side effects that may negate the benefits for some patients. I don’t blame Eli Lilly here, I blame the users.

    2. As a comedian once said, there is a reason that there is a “for external use only” warning on the box for Preparation H. Or 17 warning stickers on every step ladder sold today.

  2. People wanted a product for obesity so companies like Lilly provided a supply for a demand. Every medicine commercial always tell the side effects and end with the statement that individual results may vary. Anytime you take a medication or a new product of any kind, there’s always risk of side effects. Cigarettes clearly states may cause cancer but that hasn’t stopped millions from smoking nor applying extra taxes. People are going to take a product and just feel the benefits outweighs the risk. Not Lilly’s fault at all in my opinion.

  3. Been taking Mounjaro for about a year and a half. It’s a wonder drug for many diabetics like myself. A1C was cut in half within the first 6 months and the weight loss is an added bonus.

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL
TAKE 50% OFF

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

GET DEAL

Already a paid subscriber? Log In

GET DEAL

CYBER WEEK SPECIAL

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

Already a paid subscriber? Log In

CYBER WEEK SPECIAL
TAKE 50% OFF

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

GET DEAL

Already a paid subscriber? Log In

GET DEAL

CYBER WEEK SPECIAL

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

Already a paid subscriber? Log In